Loading Events

« All Events

Life Science Investor conference

March 10 @ 16:50 - 17:20

Magnus Corfitzen, Ascelia Pharma’s CEO will be presenting at the Life Science Conference at 16:50 CET.  Link to this virtual event is: Events – Life Science | Økonomisk Ugebrev



March 10
16:50 - 17:20

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020